AI Insight: Albemarle’s current price exceeds its PERT-weighted fair value by 27.5%, suggesting potential overvaluation. The wide range in valuation methods, notably the negative DCF values versus high analyst targets, indicates conflicting signals with significant uncertainty. Strong liquidity contrasts with weak profitability and efficiency, implying financial resilience amid operational challenges.